Neeraj Narula (N Narula)

Publication Activity (10 Years)

Years Active: 2016-2024
Publications (10 Years): 70

Top Topics

Ulcerative Colitis

Top Venues

Inflammatory bowel diseases

Journal of Crohn's & colitis

Alimentary pharmacology & therapeutics

The American journal of gastroenterology

This page only lists publications with an associated author ORCID identifier.

Publications

Neeraj Narula, Hasan Hamam, Jasmine Liu, Emily Chu Lee Wong, John K Marshall, Vipul Jairath, Stephen B Hanauer, Walter Reinisch, Parambir S Dulai
Adaptive steroid tapering impedes corticosteroid-free remissions compared to forced tapering in clinical trials of ulcerative colitis. Journal of Crohn's & colitis (2024)
Alexandra Gleave, Aryan Shah, Umair Tahir, Jedid-Jah Blom, Ethan Dong, Ayush Patel, John K Marshall, Neeraj Narula
Using Diet to Treat Inflammatory Bowel Disease: A Systematic Review. The American journal of gastroenterology (2024)
Neeraj Narula, Emily C L Wong, Parambir S Dulai, John K Marshall, Vipul Jairath, Walter Reinisch
Delayed Ustekinumab and Adalimumab Responders Have Similar Outcomes as Early Responders in Biologic-Naïve Crohn's Disease. The American journal of gastroenterology 119 (7) (2024)
Neeraj Narula, Emily C L Wong, Parambir S Dulai, John K Marshall, Vipul Jairath, Walter Reinisch
Delayed Ustekinumab and Adalimumab Responders Have Similar Outcomes as Early Responders in Biologic-Naïve Crohn's Disease. The American journal of gastroenterology (2024)
Alexandra Gleave, Aryan Shah, Umair Tahir, Jedid-Jah Blom, Ethan Dong, Ayush Patel, John K Marshall, Neeraj Narula
Using Diet to Treat Inflammatory Bowel Disease: A Systematic Review. The American journal of gastroenterology (2024)
Sunil Sadruddin Samnani, Emily Chu Lee Wong, Hasan Hamam, Parambir S Dulai, John K Marshall, Vipul Jairath, Walter Reinisch, Neeraj Narula
Outcomes of patients with prior biologic intolerance are better than those with biologic failure in clinical trials of inflammatory bowel disease. Journal of Crohn's & colitis (2024)
Mohammad Shehab, Amro Hassan, Fatema Alrashed, Adnan Abbas, Christopher Ma, Neeraj Narula, Vipul Jairath, Siddharth Singh, Talat Bessissow
Comparative Efficacy of Biologics and Small Molecule Therapies in Improving Patient-Reported Outcomes in Ulcerative Colitis: Systematic Review and Network Meta-Analysis. Inflammatory bowel diseases (2024)
Neeraj Narula, Emily C L Wong, Parambir S Dulai, John K Marshall, Vipul Jairath, Walter Reinisch
Delayed Ustekinumab and Adalimumab Responders Have Similar Outcomes as Early Responders in Biologic-Naïve Crohn's Disease. The American journal of gastroenterology 119 (7) (2024)
Neeraj Narula, Emily C L Wong, Parambir S Dulai, John K Marshall, Vipul Jairath, Walter Reinisch
Delayed Ustekinumab and Adalimumab Responders Have Similar Outcomes as Early Responders in Biologic-Naïve Crohn's Disease. The American journal of gastroenterology (2024)
Neeraj Narula, Emily C L Wong, Parambir S Dulai, John K Marshall, Vipul Jairath, Walter Reinisch
Delayed Ustekinumab and Adalimumab Responders Have Similar Outcomes as Early Responders in Biologic-Naïve Crohn's Disease. The American journal of gastroenterology 119 (7) (2024)
Neeraj Narula, Hasan Hamam, Farhad Peerani, Talat Bessissow, Brian Bressler, Parambir S Dulai, null null
Resolution of rectal bleeding by day 7 in acute severe ulcerative colitis is prognostic for post-discharge corticosteroid free clinical remission and endoscopic improvement. The American journal of gastroenterology (2024)
Emily C L Wong, Shahin Merat, Cristina Monaco, Parambir S Dulai, Vipul Jairath, John K Marshall, Walter Reinisch, Neeraj Narula
Comparative Efficacy of Infliximab Versus Tofacitinib for Inducing Remission in Biologic Naive Ulcerative Colitis: A Propensity Matched Study. Digestive diseases and sciences 68 (6) (2023)
Emily C L Wong, Parambir S Dulai, John K Marshall, Vipul Jairath, Walter Reinisch, Neeraj Narula
Matching-adjusted Indirect Comparisons vs Propensity Score Matching with Individual Patient-level Data to Estimate Treatment Efficacy. Inflammatory bowel diseases (2023)
Emily C L Wong, Shahin Merat, Cristina Monaco, Parambir S Dulai, Vipul Jairath, John K Marshall, Walter Reinisch, Neeraj Narula
Comparative Efficacy of Infliximab Versus Tofacitinib for Inducing Remission in Biologic Naive Ulcerative Colitis: A Propensity Matched Study. Digestive diseases and sciences 68 (6) (2023)
Virginia Solitano, Sudheer K Vuyyuru, John K MacDonald, Alexa Zayadi, Claire E Parker, Neeraj Narula, Laurent Peyrin-Biroulet, Silvio Danese, Brian G Feagan, Siddharth Singh, Christopher Ma, Vipul Jairath
Efficacy and safety of advanced oral small molecules for inflammatory bowel disease: Systematic review and meta-analysis. Journal of Crohn's & colitis (2023)
Emily C L Wong, Shahin Merat, Cristina Monaco, Parambir S Dulai, Vipul Jairath, John K Marshall, Walter Reinisch, Neeraj Narula
Comparative Efficacy of Infliximab Versus Tofacitinib for Inducing Remission in Biologic Naive Ulcerative Colitis: A Propensity Matched Study. Digestive diseases and sciences 68 (6) (2023)
Sudheer K Vuyyuru, Tran M Nguyen, Malcolm Hogan, Tim Raine, Nurulamin M Noor, Neeraj Narula, Bram Verstockt, Brian G Feagan, Siddharth Singh, Christopher Ma, Vipul Jairath
Endoscopic and Histological Placebo Rates in Crohn's Disease Clinical Trials: A Systematic Review and Meta-analysis. Inflammatory bowel diseases (2023)
Sudheer Kumar Vuyyuru, Virginia Solitano, Neeraj Narula, Matthew James Lee, John K MacDonald, Jeffrey D McCurdy, Siddharth Singh, Christopher Ma, Vipul Jairath
Pharmacological therapies for the management of fistulising Crohn's disease: A systematic review and meta-analysis. Journal of Crohn's & colitis (2023)
Mathieu Uzzan, Yoram Bouhnik, Maria Abreu, Harris A Ahmad, Shashi Adsul, Hilde Carlier, Marla Dubinsky, Matthew Germinaro, Vipul Jairath, Irene Modesto, Eric Mortensen, Neeraj Narula, Ezequiel Neimark, Alessandra Oortwijn, Marijana Protic, David T Rubin, Young S Oh, Jolanta Wichary, Laurent Peyrin-Biroulet, Walter Reinisch
Declining enrolment and other challenges in IBD clinical trials: Causes and potential solutions. Journal of Crohn's & colitis (2023)
Emily C L Wong, Shahin Merat, Cristina Monaco, Parambir S Dulai, Vipul Jairath, John K Marshall, Walter Reinisch, Neeraj Narula
Comparative Efficacy of Infliximab Versus Tofacitinib for Inducing Remission in Biologic Naive Ulcerative Colitis: A Propensity Matched Study. Digestive diseases and sciences 68 (6) (2023)
Cara Pray, Neeraj Narula
Editorial: Moving towards prognostic endoscopic scoring in IBD. Alimentary pharmacology & therapeutics 59 (1) (2023)
Emily Chu Lee Wong, Parambir S Dulai, Badar Hasan, John K Marshall, Walter Reinisch, Neeraj Narula
Combined Histologic and Endoscopic Endpoints at Post-induction Lack Additional Prognostic Value Compared to Endoscopic Improvement Alone in Ulcerative Colitis: A Post-hoc Analysis of the VARSITY study. Journal of Crohn's & colitis (2023)
Cara Pray, Neeraj Narula
Editorial: Moving towards prognostic endoscopic scoring in IBD. Alimentary pharmacology & therapeutics 59 (1) (2023)
Emily C L Wong, Parambir S Dulai, John K Marshall, Vipul Jairath, Walter Reinisch, Neeraj Narula
Predicting Endoscopic Improvement in Ulcerative Colitis Using the Ulcerative Colitis Severity Index. Inflammatory bowel diseases (2023)
Cara Pray, Neeraj Narula
Editorial: Moving towards prognostic endoscopic scoring in IBD. Alimentary pharmacology & therapeutics 59 (1) (2023)
Achuthan Aruljothy, Siddharth Singh, Neeraj Narula, Gordon William Moran, Sudheer K Vuyyuru, Malcolm Hogan, Alexa Zayadi, John K MacDonald, Benedicte Caron, Silvio Danese, Laurent Peyrin Biroulet, Christopher Ma, Vipul Jairath
Systematic review with meta-analysis: Medical therapies for treatment of ulcerative proctitis. Alimentary pharmacology & therapeutics (2023)
Sudheer K Vuyyuru, Christopher Ma, Tanmay Sharma, Tran M Nguyen, Talat Bessissow, Neeraj Narula, Siddharth Singh, Florian Rieder, Vipul Jairath
Characteristics of Interventional Trials for Patients Living With Intestinal Stoma Registered in ClinicalTrials.gov With a Focus on Inflammatory Bowel Disease. Inflammatory bowel diseases (2023)
Neeraj Narula, Emily C L Wong, Parambir S Dulai, John K Marshall, Vipul Jairath, Walter Reinisch
Vedolizumab and Adalimumab in Biologic-Naïve Ulcerative Colitis: Comparison of Patient-Level Clinical Trial Data and VARSITY for Week 6 Clinical Remission. Digestive diseases and sciences (2023)
Sudheer K Vuyyuru, Christopher Ma, Tanmay Sharma, Tran M Nguyen, Talat Bessissow, Neeraj Narula, Siddharth Singh, Florian Rieder, Vipul Jairath
Characteristics of Interventional Trials for Patients Living With Intestinal Stoma Registered in ClinicalTrials.gov With a Focus on Inflammatory Bowel Disease. Inflammatory bowel diseases (2023)
Emily C L Wong, Shahin Merat, Cristina Monaco, Parambir S Dulai, Vipul Jairath, John K Marshall, Walter Reinisch, Neeraj Narula
Comparative Efficacy of Infliximab Versus Tofacitinib for Inducing Remission in Biologic Naive Ulcerative Colitis: A Propensity Matched Study. Digestive diseases and sciences (2023)
Sudheer K Vuyyuru, Christopher Ma, Tanmay Sharma, Tran M Nguyen, Talat Bessissow, Neeraj Narula, Siddharth Singh, Florian Rieder, Vipul Jairath
Characteristics of Interventional Trials for Patients Living With Intestinal Stoma Registered in ClinicalTrials.gov With a Focus on Inflammatory Bowel Disease. Inflammatory bowel diseases (2023)
Neeraj Narula, Emily C L Wong, Parambir S Dulai, John K Marshall, Jean Frederic Colombel, Walter Reinisch
Outcomes of Passable and Non-passable Strictures in Clinical Trials of Crohn's Disease: A Post-hoc Analysis. Journal of Crohn's & colitis 15 (10) (2022)
Emily C L Wong, Parambir S Dulai, John K Marshall, Vipul Jairath, Walter Reinisch, Neeraj Narula
Predictors of Clinical Remission to Placebo in Clinical Trials of Crohn's Disease. Inflammatory bowel diseases (2022)
Emily Chu Lee Wong, Parambir S Dulai, Neeraj Narula
Correspondence on "PICaSSO Histologic Remission Index (PHRI) in ulcerative colitis: development of a novel simplified histological score for monitoring mucosal healing and predicting clinical outcomes and its applicability in an artificial intelligence system" by Gui et al . Gut (2022)
Neeraj Narula, Emily C L Wong, Parambir S Dulai, John K Marshall, Vipul Jairath, Walter Reinisch
Comparative Effectiveness of Biologics for Endoscopic Healing of the Ileum and Colon in Crohn's Disease. The American journal of gastroenterology 117 (7) (2022)
Emily Chu Lee Wong, Parambir S Dulai, John K Marshall, Vipul Jairath, Walter Reinisch, Neeraj Narula
Editorial: is it not just PROs, but the most important individual PRO, that really matters in Crohn's disease? Authors' reply. Alimentary pharmacology & therapeutics 55 (8) (2022)
Paul Bahnam, Jurij Hanzel, Christopher Ma, Lily Zou, Neeraj Narula, Siddharth Singh, Brennan Kahan, Vipul Jairath
Most placebo-controlled trials in inflammatory bowel disease were underpowered because of overestimated drug efficacy rates: Results from a systematic review of induction studies. Journal of Crohn's & colitis (2022)
Badar Hasan, Kanwarpreet Singh Tandon, Rafael Miret, Sikandar Khan, Amir Riaz, Adalberto Gonzalez, Asad Ur Rahman, Roger Charles, Neeraj Narula, Fernando J Castro
Ustekinumab does not increase risk of new or recurrent cancer in inflammatory bowel disease patients with prior malignancy. Journal of gastroenterology and hepatology 37 (6) (2022)
Rocio Sedano, Malcolm Hogan, Guangyong Zou, Neeraj Narula, Siddharth Singh, Christopher Ma, Brian G Feagan, Vipul Jairath
Comparison of the Relative Sensitivity of Clinical, Endoscopic, and Histologic Remission for Detection of Treatment Efficacy in Ulcerative Colitis Trials. Inflammatory bowel diseases (2022)
Manasi Agrawal, Mario Bento- Miranda, Samantha Walsh, Neeraj Narula, Jean Frederic Colombel, Ryan C Ungaro
Prevalence and Progression of Incidental Terminal Ileitis on Non-diagnostic Colonoscopy: A Systematic Review and Meta-analysis. Journal of Crohn's & colitis 15 (9) (2022)
Parambir S Dulai, Emily C L Wong, Walter Reinisch, Jean Frederic Colombel, John K Marshall, Neeraj Narula
Decision Support Tool Identifies Ulcerative Colitis Patients Most Likely to Achieve Remission With Vedolizumab vs Adalimumab. Inflammatory bowel diseases 28 (10) (2022)
Neeraj Narula, Cara Pray, Emily Chu Lee Wong, Jean Frederic Colombel, John K Marshall, Marco Daperno, Walter Reinisch, Parambir S Dulai
Categorising Endoscopic Severity of Crohn's Disease Using the Modified Multiplier SES-CD [MM-SES-CD]. Journal of Crohn's & colitis 16 (7) (2022)
Neeraj Narula, Shahin Merat, David Liu, David Pugatch, Walter Reinisch
Time to endorse a sensitive method for scoring endoscopic activity of ulcerative colitis in clinical research. Journal of Crohn's & colitis (2022)
Neeraj Narula, Emily Chu Lee Wong, Parambir S Dulai, John K Marshall, Vipul Jairath, Walter Reinisch
The Performance of the Rutgeerts Score, SES-CD, and MM-SES-CD for Prediction of Postoperative Clinical Recurrence in Crohn's Disease. Inflammatory bowel diseases (2022)
Emily Chu Lee Wong, Paul Moayyedi, Neeraj Narula
Beyond the White pill: Advocating for racial diversity in IBD trials. Journal of Crohn's & colitis (2022)
Emily Chu Lee Wong, Parambir S Dulai, John K Marshall, Vipul Jairath, Walter Reinisch, Neeraj Narula
Resolution of dominant patient-reported outcome at end of induction predicts clinical and endoscopic remission in Crohn's disease. Alimentary pharmacology & therapeutics 55 (9) (2022)
Nilesh Chande, Siddharth Singh, Neeraj Narula, Morris Gordon, M Ellen Kuenzig, Tran M Nguyen, John K MacDonald, Brian G Feagan
Medical Management Following Surgical Therapy in Inflammatory Bowel Disease: Evidence from Cochrane Reviews. Inflammatory bowel diseases 27 (9) (2022)
Cara Pray, Emily Chu Lee Wong, Achuthan Aruljothy, Parambir S Dulai, John K Marshall, Walter Reinisch, Neeraj Narula
Ulcer Size After Induction Therapy Performs Better Than Symptom Assessment for Prediction of One Year Endoscopic Remission in Crohn's Disease: A Post Hoc Analysis. Inflammatory bowel diseases (2022)
Neeraj Narula, Emily C L Wong, John K Marshall, Vipul Jairath, Parambir S Dulai, Walter Reinisch
Long-Term Outcomes of Early vs Delayed Responders to Vedolizumab and Adalimumab: A Post Hoc Analysis of the VARSITY Study. The American journal of gastroenterology (2022)
Emily C L Wong, John K Marshall, Walter Reinisch, Neeraj Narula
Body Mass Index Does Not Impact Clinical Efficacy of Ustekinumab in Crohn's Disease: A Post Hoc Analysis of the IM-UNITI Trial. Inflammatory bowel diseases 27 (6) (2022)
Emily Chu Lee Wong, Arif Yusuf, Jagoda Pokryszka, Parambir S Dulai, Jean Frederic Colombel, John K Marshall, Walter Reinisch, Neeraj Narula
Increased Expression of Interleukin-13 Receptor in Ileum Associated With Nonresponse to Adalimumab in Ileal Crohn's Disease. Inflammatory bowel diseases (2022)
Emily C L Wong, Parambir S Dulai, John K Marshall, Vipul Jairath, Walter Reinisch, Neeraj Narula
Comparative Efficacy of Infliximab vs Ustekinumab for Maintenance of Clinical Response in Biologic Naïve Crohn's Disease. Inflammatory bowel diseases (2022)
Emily C L Wong, Elisa Buffone, So Jeong Lee, Parambir S Dulai, John K Marshall, Walter Reinisch, Neeraj Narula
End of Induction Patient-reported Outcomes Predict Clinical Remission but Not Endoscopic Remission in Crohn's Disease. Journal of Crohn's & colitis 15 (7) (2021)
Neeraj Narula, Achuthan Aruljothy, Emily Chu Lee Wong, Ravi Homenauth, Abdul-Aziz Alshahrani, John K Marshall, Walter Reinisch
The impact of ustekinumab on extraintestinal manifestations of Crohn's disease: A post hoc analysis of the UNITI studies. United European gastroenterology journal 9 (5) (2021)
Neeraj Narula, Emily Chu Lee Wong, Raed AlRamdan, Hasan Bualbanat, John K Marshall, A Hillary Steinhart, Tomer Greener, Mark S Silverberg
Comparative effectiveness of higher adalimumab maintenance therapy versus standard dose in anti-tumor necrosis factor experienced Crohn's disease patients: A propensity-score matched cohort analysis. Journal of gastroenterology and hepatology 36 (10) (2021)
Neeraj Narula, Emily C L Wong, Mahshid Dehghan, Andrew Mente, Sumathy Rangarajan, Fernando Lanas, Patricio Lopez-Jaramillo, Priyanka Rohatgi, P V M Lakshmi, Ravi Prasad Varma, Andres Orlandini, Alvaro Avezum, Andreas Wielgosz, Paul Poirier, Majid A Almadi, Yuksel Altuntas, Kien Keat Ng, Jephat Chifamba, Karen Yeates, Thandi Puoane, Rasha Khatib, Rita Yusuf, Kristina Bengtsson Boström, Katarzyna Zatonska, Romaina Iqbal, Liu Weida, Zhu Yibing, Li Sidong, Antonio Dans, Afzalhussein Yusufali, Noushin Mohammadifard, John K Marshall, Paul Moayyedi, Walter Reinisch, Salim Yusuf
Association of ultra-processed food intake with risk of inflammatory bowel disease: prospective cohort study. BMJ (Clinical research ed.) 374 (2021)
Neeraj Narula, Anne Hu, Geoffrey C Nguyen, Jagadish Rangrej, John K Marshall
Periodic Colonoscopies Are Associated with Improved Survival and Prognosis of Colorectal Cancer in Ulcerative Colitis. Digestive diseases and sciences (2021)
Parul Tandon, Neeraj Narula
Editorial: methotrexate in patients with Crohn's disease refractory to anti-TNF therapy-moving backwards yet forward? Alimentary pharmacology & therapeutics 53 (8) (2021)
Conor Bell, Parul Tandon, Eric Lentz, John K Marshall, Neeraj Narula
Systematic review and meta-analysis: Safety of vedolizumab during pregnancy in patients with inflammatory bowel disease. Journal of gastroenterology and hepatology 36 (10) (2021)
Neeraj Narula, Emily Chu Lee Wong, Jean Frederic Colombel, William J Sandborn, Marc Ferrante, John K Marshall, Walter Reinisch, Parambir S Dulai
Early Reduction in MM-SES-CD Score After Initiation of Biologic Therapy is Highly Specific for One-Year Endoscopic Remission in Moderate to Severe Crohn's Disease. Journal of Crohn's & colitis (2021)
Neeraj Narula, Emily Chu Lee Wong, Jean-Frederic Colombel, William J Sandborn, John Kenneth Marshall, Marco Daperno, Walter Reinisch, Parambir S Dulai
Predicting endoscopic remission in Crohn's disease by the modified multiplier SES-CD (MM-SES-CD). Gut (2021)
Jamie Zhen, John K Marshall, Geoffrey C Nguyen, Ashish Atreja, Neeraj Narula
Impact of Digital Health Monitoring in the Management of Inflammatory Bowel Disease. Journal of medical systems 45 (2) (2021)
Neeraj Narula, Achuthan Aruljothy, Abdul-Aziz Alshahrani, Ma'ayan Fadida, Mona Al-Saedi, John K Marshall, David T Rubin, Britt Christensen
Histologic remission does not offer additional benefit for ulcerative colitis patients in endoscopic remission. Alimentary pharmacology & therapeutics 52 (11-12) (2020)
M T Balart, Lindsey A Russell, Neeraj Narula, G Bajaj, U Chauhan, K J Khan, A N Marwaha, E Ching, J Biro, S Halder, F Tse, J K Marshall, S M Collins, Paul Moayyedi, P Bercik, E F Verdu, Grigorios I Leontiadis, David Armstrong, Maria Ines Pinto-Sanchez
Declining Use of Corticosteroids for Crohn's Disease Has Implications for Study Recruitment: Results of a Pilot Randomized Controlled Trial. Journal of the Canadian Association of Gastroenterology 4 (5) (2020)
Priya Sehgal, Neeraj Narula
Letter: mesalazine-a safe drug with rare serious adverse events? Authors' reply. Alimentary pharmacology & therapeutics 51 (11) (2020)
Adam Tepler, Neeraj Narula, Richard M Peek, Anish Patel, Cyrus Edelson, Jean Frederic Colombel, Shailja C Shah
Systematic review with meta-analysis: association between Helicobacter pylori CagA seropositivity and odds of inflammatory bowel disease. Alimentary pharmacology & therapeutics 50 (2) (2019)
Parambir S Dulai, Siddharth Singh, Vipul Jairath, Christopher Ma, Neeraj Narula, Niels Vande Casteele, Laurent Peyrin Biroulet, Severine Vermeire, Geert D'Haens, Brian G Feagan, William J Sandborn
Prevalence of endoscopic improvement and remission according to patient-reported outcomes in ulcerative colitis. Alimentary pharmacology & therapeutics 51 (4) (2019)
Neeraj Narula, Sameer Masood, Samira Shojaee, Brandon McGuinness, Saama Sabeti, Arianne Buchan
Safety of Propofol versus Nonpropofol-Based Sedation in Children Undergoing Gastrointestinal Endoscopy: A Systematic Review and Meta-Analysis. Gastroenterology research and practice 2018 (2018)
P Sehgal, Jean Frederic Colombel, A Aboubakr, Neeraj Narula
Systematic review: safety of mesalazine in ulcerative colitis. Alimentary pharmacology & therapeutics 47 (12) (2018)
Neeraj Narula, Mohan Cooray, Rebecca Anglin, Zack Muqtadir, Alisha Narula, John K Marshall
Impact of High-Dose Vitamin D3 Supplementation in Patients with Crohn's Disease in Remission: A Pilot Randomized Double-Blind Controlled Study. Digestive diseases and sciences 62 (2) (2016)